Abstracl-Warm F. N. and BEHNKE J. M. 1992. Stimuli for acquired resistance to Heligmosonroides po/ygJws from intestinal tissue resident L3 and L4 larvae. Iniernaiional Journalfor Parasitology 22: 699-710. L3 and L4 stages of H.po/ygyrus were prevented from developing further and were probably killed within 24 h of treatment with ivermectin although total parasite burdens, particularly when treatment was given 4-6 days after infection. declined over a longer period lasting several days. Strong resistance to challenge infection was expressed by infected mice dosed with ivermectin during the tissue phase of larval development.
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INTRODUCTION
THE longevity of parasitic nematodes in vertebrate hosts is still an enigmatic phenomenon for which there is no conclusive explanation. Both tissue-dwelling species such as the filariae and intestinal species such as hookworms have the capacity to cause chronic infections in man and his domestic animals (reviewed by Behnke, 1987; Behnke. Barnard & Wakelin, in press; Nutman, 1989 ) and yet their evasive strategies, whilst anticipated on evolutionary considerations vis-d-vis the arms race (Behnke & Barnard, 1990) . are hardly understood.
The possibility that complex immunomodulatory strategies have evolved to downregulate potentially protective host responses has been explored extensively and a variety of mechanisms have been considered (Barr&a, 1984; Behnke, 1987; Nutman, Kumaraswami & Ottesen, 1987) .
The murine trichostrongylid
Heligmosomoides polygyrus, a widely investigated model species in this context, is a natural parasite of mice but in several *To whom all correspondence should be addressed respects the parasitic life cycle of this worm is unusual. The L3 larvae penetrate through the mucosa and come to lie in the muscularis externa where development involving two moults takes place (Bryant, 1973) . After 7-8 days the preadults emerge into the intestinal lumen where they reside as adults for up to IO months postinfection (pi.) depending on strain of mouse (Ehrenford, 1954; Robinson, Wahid, Behnke & Gilbert, 1989) . On primary exposure to the parasite, there is no significant loss of worms during this tissue phase, despite the inflammatory reaction provoked by the developing stages, their excretory/secretory (ES) products and the sheaths left behind after moulting (Liu, 1965; Sukhdeo, O'Grady & Hsu, 1984) .
On secondary exposure, these sites of development in the gut tissues become the foci of intense reactions resulting in prominent granulomatous lesions (Prowse, Mitchell, Ey & Jenkin, 1979) . Larvae developing in immune mice are usually stunted (Bartlett & Ball, 1974; Sitepu, Dobson & Brindley, 1985) , take longer to complete their tissue phase of development (Ey. 1988a), may become arrested (Behnke & Parish, 1979a) and are less fecund as adults (Enriquez, Scarpino, Cypess & Wassom, 1988; Kerboeuf, 1985; Sitepu rt al., 1985) . These manifestations of acquired resistance are all well documented.
However, there is still controversy over the stage which finally succumbs to host immunity. Initially it was believed that the intense foci of inflammation surrounding developing larvae killed the parasites in situ (Bartlett & Ball, 1974; Chaicumpa, Prowse. Ey & Jenkin, 1977) but it was subsequently shown that numerous worms survived for a very long time in such lesions. possibly returning to the gut lumen to be expelled as preadults (Behnke & Parish, 1979b : Cypess. Lucia. Dunsford & Enriquez. 1988 .
There is little argument that the tissue larval stages of Hplygyrus provide essential stimuli for the expression of host-protective immunity (Van Zandt. 1961; Jacobson, Brooks & Cypess, 1982) 1983; Cayzer & Dobson, 1983; Enriquez, Cypess & Wassom, 1988; Pritchard & Behnke, 1985) . This has been clearly demonstrated in experiments where infections terminated before the adult phase of infection were shown to generate considerably more potent immunity than those in which the infection was allowed to progress to patency (Behnke &, Robinson, 1985; Kerboeuf & Jolivet, 1984) .
Although protective immunity is most effectively acquired when exposure is limited to tissue larvae, the exact stages of H.po1ygyz.a responsible for stimuli eliciting acquired immunity still remain to be elucidated. Following on from our earlier work, the studies of Enriquez, Cypess & Wassom (1988) (Jenkins & Behnke. 1977) . Adult parasites were recovered by a 6 h incubation, at 37°C of small intestines suspended m a gauze, in 50 ml beakers containing Hanks's saline as described by Jenkins & Behnke (1977) . Larval stages of the parasite were recovered by separate digestion of intestinal tissues from individual mice in a mixture of pepsin, hydrochloric acid (5 g pepsin (BDH), 5 ml cont. HCI and 500 mldistilled water), in conical flasks maintained in a watcrbath at 37°C for I.5 h. Following incubation the contents were poured through a stainless steel mesh (size 38 llrn. Endecott Sieves) held in a separating funnel. The funnel was then rinsed with PBS five times into a beaker and the fluid containing worms was transferred to a IO cm Petri dish for counting under a dissecting microscope. Conway, 1989) . Pyrantel embonate (Strongid-P paste. Pfizer) was administered orally to some mice in experiments 7 and IO at a dose of 100 mg kg ', which is known to be adequate for removing all adult worms from the intestinal lumen (Behnke & Wakelin. 1977 anti-mouse IgG (whole molecule, Sigma) or IgGl (Serotec) were used to measure total or subclass specific responses. After addition of the substrate (P-nitrophenylphosphatase) colour changes were read at 410 nm on a Dynatech MR700 Microplate Reader. Sera were assayed individually after storage at ~ 40°C. Each plate included control hyperimmune serum (HIM) which was raised as described by Behnke & Parish (1979b) and naive serum and these were used to calculate the relative response index (RRI). Sera were assayed in triplicate and the mean optical density (O.D.) for individual sera was expressed as a percentage of the O.D. obtained with the hyperimmune reference serum. after subtraction of the value for naive control serum from each value. RRIs measured on individual sera on different occasions showed little variation and the results were consistently reproducible.
Mmsurement
The same stocks of aliquoted HIM and control naive serum were used throughout the study. The spectrum of antigens recognized by antibodies in the sera of infected mice was examined by the Western blotting technique essentially as described by Carr & Pritchard (1987) . PBS-soluble adult worm antigen was electrophoretically transferred to nitrocellulose membranes (Schleicher & Scuell) following separation on 5-20% gradient SDS-PAGE. Strips of membrane were blocked with 5% skimmed milk in PBSTween 20 (0.05%) and then incubated overnight at 4°C with appropriate test sera (I: 100) using 5% skimmed milk in PBSTween 20. After washing in PBS-Tween 30 the strips were Incubated with "'I-sheep anti-mouse polyvalent immunoglobulins (18.5 kBq;'strip, Amersham) for 2 h at room temperature.
Following washing in PBS-Tween 20 (3 x 20 min) the strips were air dried. fixed to the interior of an X-ray cassette and exposed to an X-ray film (Fuji) at ~ 80°C in the presence of an intensifying screen. The molecular weights were estimated with reference to the migration of standard molecular weight markers.
S/urixfiwl analy.sis o/ rr.w/~.c. The results are presented as group mean values * standard error (s E 21 ). Non-parametric statistical procedures were used to analyse the data sets. because of small sample sires (Sokal & Rohlf, 1969) . When more than two groups required comparison at a single time point the Kruskal-Wallis statistic H was calculated to determine whether there was a significant treatment effect. II significant, specific groups were compared to the control group (or as stated) by the Mann-Whitney c' test. Correlations between variables were tested by the Spearman Rank Correlation Test and the statistic r.) is given, as appropriate. Probabilities were calculated from statistics tables and arc presented as follows: *P = 0.05: **0.05 > P 2 0.02: ***0.02 > P > 0.01: ****0.01 > P > 0.001; *****p < 0.001. _ Table 1. further development of worms, within hours of treatment, otherwise we could not be certain that elicited immunity would be attributable to stimuli from parasite stages resident in host tissues prior to or at the time of treatment. Therefore, it was essential to assess the speed of larvicidal activity of IV after injection, a feature not examined in earlier studies (Wahid et al., 1989) .
RESULTS

The ejfcct of'ivrrmectin (IV) on tissue residmt .xtugc.y c!f
The results of six experiments, each examining a different period of exposure, are illustrated in Fig. I . It is evident that in all cases stable worm populations were recovered from control mice over the 3-day period of observation.
Furthermore, the numbers of worms recovered in relation to the inocula administered show that recovery by pepsin digestion was efficient and that few worms were missed. Additional, infected but not treated, control groups were killed 3 weeks after each infection and the worms were isolated by the standard Baerman procedure at a time when all the worms could be accurately recovered. These control groups yielded 162, 182, 214, I55 and 199 worms in Experiments 2-6, respectively, thereby confirming that the recovery of worms in the early stages of infection by the digestion technique was accurate and efficient.
By comparison with control groups relatively few worms were recovered from mice treated with IV. When IV was given 12 h after infection the reduction in worm recovery 24 h later (i.e. 1.5 days after infection) was 71.2%. By 48 hit was 87.5% and by 72 h, 99.5%. When older infections were treated the yield of parasites was greater. For example when the 6-day infection was treated ( Fig. 1 F, Experiment 6 144h ), the reduction 24 h later was only 19.7%.
However, it is evident that while worms in control mice continued developing normally in each case, those in IV-treated mice showed no further growth as adjudged by their size 2472 h after treatment (Fig. 2) . Furthermore careful examination of these specimens showed that in no case did worms from mice treated with IV 12, 24 or 48 h after infection moult to the L4 stage ( Fig. 2A-C) and none treated 72 and 144 h p.i. developed into juvenile worms. In all cases the mean length of worms from control groups was longer than from IV-treated groups 24 h after administration of the drug.
One further control was used to confirm that worms in animals treated with IV died rapidly after treatment. In Experiment 6 in which the reduction of worm burden 24 h after treatment was relatively small, additional groups of mice were treated as follows. The intestine was scraped gently and the tissues were then incubated without enzyme in a standard Baerman procedure. The recovery of worms from control mice treated in this way 24,48 and 72 h after treatment with saline was 118, 183 and 186. Mice dosed with IV yielded 41, I4 and three worms showing that the parasites in treated mice were far less mobile, since this recovery technique depends on the parasites migrating out of the tissues. After incubation the tissues were digested in enzyme and the yields were as follows, control mice 65, 44 and 41, respectively (indicating that the majority had migrated out earlier), whilst those of treated mice were 105, 125 and 128 (indicating that the majority has stayed in situ).
Acquired immunity elicited during infections of varying duration, abbreviated during the tissue phase of development
Four experiments, in which ivermectin was administered to groups of mice at varying time points following infection, were carried out to determine the minimal period of infection required to elicit acquired immunity.
Experiments 7-10 involved female NIH mice, a primary infection with 250 larvae, followed by ivermectin treatment of relevant groups, a period of rest to allow ivermectin to be metabolized and eliminated by the host, followed by a challenge infection. The exact protocol for each experiment, together with details of minor variations in detail between the experiments and the statistical analysis, are presented in Table 1 . For greater ease of interpretation the data from Experiments 7-9 are also expressed in terms of percentage protection in Fig. 3 .
In Experiment 7 ivermectin was given 48 and 96 h and 6, 8 and 10 days after infection. Acquired immunity exceeded 95% in all cases with the weakest (96. I %) in the group treated 48 h after exposure. The second experiment in this series (Experiment 8) examined earlier periods of treatment. Again **** 6. I f 6.0 (IO) **** 0.2zIzO.2 (6) 0 (6)**** t The mice in Experiments 7-9 were female NIH, those in Experiment 10 were female SWR. Challenge infections comprised 150 L3 (Experiment 7), 100 L3 (Experiments 8 and 9) or 120 L3 (Experiment 10) and were given 38,34.35 and 35 days after the primary infection, respectively.
1 The primary infection consisted of 250 L3 in each experiment. Additional groups of mice were killed on day 21 aftcl primary infection to monitor the level of establishment and the numbers of worms recovered were as follows: Experiment 7. 242.5& 16.4 (n=4); Experiment 8,214.7*8.7 (n=3); Experiment 9, 171.0+9.5 (n=4) and Experiment 10, 178.0*3.4(~=4). 5 Groups of mice were treated at the hours or days shown after primary infection. In each case additional groups of two to three mice (not shown), infected with the primary infection and then treated at the times shown. were killed on day 21 p.i. to confirm the efficacy of ivermectin. Of 62 mice examined across the four experiments only one mouse in Experiment 8 (treated with ivermectin 48 h after infection) carried 126 worms. The remaining mice were all without worms.
11 Control groups for persistence of ivermectin. 7 These two groups were not treated with ivermectin but were given pyrantel a few days (Experiment 7. day 35: Experiment 9, day 33) before challenge to eliminate adult worms.
Stutistical analysis ~7fresuits
Experiment 7, H = 39.442 (P i 0.001); Experiment 8, H = 29.070 (P < 0.001); Experiment 9, H = 43.196 (P > 0.0001); Experiment 10. H = 25.259 (P = 0.00012).
Additional comparisons were made using the Mann-Whitney U test and control groups (no primary infection and no anthelmintic treatment) in each case. **0.05 P P 2 0.025. ****0.01 > P 2 0.001. treatment with ivermectin after 72 h of infection generated solid resistance to challenge. Earlier treatment produced acquired immunity but variable in degree ranging among individual mice from 0 to 100%. Groups treated 12, 24, 36 and 48 h after infection had variable worm burdens following challenge with curiously fewer worms in the groups treated 12 and 36 h compared with those treated 24 and 48 h after infection, respectively.
However, in each case there was a significant reduction in worms relative to controls and we attribute the lack of a consistent pattern to small sample sizes at a time when events are delicately poised vis-ri-vis appropriate stimulation for acquired immunity. Because of this variation in the 12248 h period, a third experiment was carried out in which larger sample sizes were employed particularly in groups treated 12 and 24 h after infection (Experiment 9). This time treatment 12 h after infection did not generate significant protection from challenge but treatment at 24 h gave a 72% reduction in worm burden and comparable reduction in groups treated 60 and 72 h after exposure. Overall it can be seen from these data that infections terminated up to 60 h postinfection (p.i.) were surprisingly effective at eliciting acquired immunity in NIH mice, despite some variation among groups and between experiments.
In contrast all mice treated with IV after 60 h p.i. showed > 95% protection.
*,lrrth experiment along the same lines was ceiled out in SWR mice which expel worms from the fifth week of a primary infection (Table I, Experiment IO). Accordingly the period to challenge was reduced to 4 weeks on this occasion, to ensure that comparisons could be made before the control mice also began to reject parasites. In this case a 12 h period of exposure was sufficient to elicit 83.7% protection to challenge.
IgG and IgCl serum antibody responses to infection
Antibody responses were measured in Experiment 9 using adult worm homogenate antigen in ELISA and the results are presented in Fig. 4 . Sera taken at autopsy, 5 weeks after challenge, were also analysed for responses to L4 antigens and these results are given in Fig. 5 . It is evident that the longer the infection was allowed to progress the more intense an antibody response was elicited. Following challenge the differences between the groups were further exaggerated in both total IgG and IgGl subclass antibody. Moreover, there was an almost perfect correlation between the intensity of the IgG 1 antibody response to L4 and adult worm antigens and the percentage protection at autopsy 5 weeks after challenge infection.
Recognition of parasite antigens
The pattern of recognition of antigens was studied using the Western blotting technique (data not shown). Four antigens, 123, 62, 46 and 34 kDa were strongly recognized by the control hyperimmune serum. None were seen by control naive serum. Sera from mice exposed to abbreviated infections followed by challenge recognized all four antigens, although the intensity of recognition varied. In general sera from mice exposed to longer periods of primary exposure exhibited stronger recognition of these antigens. Challenge control sera recognized only the 123 and 34 kDa antigens.
An additional three antigens of approximate molecular weight 16, 18 and 20 kDa were recognized by sera from the experimental groups, particularly by mice from group H which had been exposed to a 6-day immunizing infection and showed solid resistance to challenge. These three bands were weakly recognized by control hyperimmune serum and there was also weak reactivity in the challenge control group.
DISCUSSION
Although H.polygyrus is considerably more resistant to ivermectin than other parasitic nematodes, doses of IO-20 mg kg-' are totally effective in eradicating the worms (Wahid et al., 1989) . However, before using IV to abbreviate infections at crucial stages of larval development, it was necessary to determine precisely how rapidly the drug exerted its effect on parasites, an aspect not considered in earlier publications. Our data (Fig. 1) show that the recovery of early developmental stages is reduced by over 70% in the 24 h period following treatment. The remaining worms recovered by digestion may have been alive at autopsy, but measurements showed that there was no growth and development after treatment (Fig. 2 ) and we are therefore confident that mice treated 1248 h after infection did not experience L4 stages at all. Treatment at 72 and 144 h resulted in a greater proportion of the worm burden being recovered by digestion. These L4 were considerably larger than the earlier stages but again did not grow from the time of treatment (Fig. 2D ,E) and were considered to be immobilized and/or dead. Their slower loss was likely attributed to a greater size and the associated difficulties in their complete removal from the muscularis externa by the host response, rather than to resistance to IV. We conclude that ivermectin at the dose employed immobilized the worms rapidly, within 24 h, enabling their destruction by a local inflammatory and granulomatous reaction and consequently all the antigenic components of these stages were made available to the host's immune system. Previous attempts to induce immunity to H. polygyrus using infective larvae have had mixed fortunes. Vaccination with dead exsheathed larvae given by smaller doses being equally effective in outbred mice (Hosier, Sackman & Idell, 1974) , protection in inbred C57BL and AKR mice never exceeded 30% (Lueker & Hepler, 1975) . Acquired immunity was also induced successfully by intravenous injection of live L3 larvae. a proportion of which succeeded in migrating to the mucosa and developed normally. Anthelmintic treatment was given IO days after the last of one to three injections, allowing in the latter cases some adult worms temporary residence before challenge. After one such inoculation protection was < 50%. However, more recently Larrick et ul. that subcutaneous injections of L3 (isolated on day 2) and L4 induced acquired immunity to H.pofygyrus in BALB/c mice. Our results confirm and extend their findings, showing for the first time that L3 stages in situ in the intestinal mucosa provide key antigenic stimuli for acquired resistance in responder mouse strains.
During the first 12-24 h period of infection, mice would have experienced little else apart from the invasive L3 stages, in the mucosa and submucosa (Sukhdeo et al., 1984) . The worms do not reach the muscularis externu until l-3 days after infection and the moult to the L4 occurs 90-94 h pi., although signs of development of L4 features become apparent from 60 h (Bryant, 1973) . Clearly, on the basis of our results, these early invasive stages are potently immunogenic even during the first 36 h period of infection.
It is perhaps pertinent that mice vaccinated with L3 larvae developed intense antibody responses to a common somatic antigen of L3 and adult worms and to cuticular antigens of invasive larvae but did not show anti-L3-ES antibody activity (Ey, l988a), and whilst we did not test sera for anti-L3-ES activity, it is probable that our immunizing protocol was superior in this respect. Indeed immunization with repeated doses of L3-ES products eventually induced detectable resistance to challenge, but overall percentage protection was still poorer than in our experiments with 24 h periods of exposure to infection (Ey, 1988a) . Furthermore, whereas vaccination with live 2-day p.i. L3 generated 60% protection (Larrick et al., 1991) our SJL mice showed 83.7 and 91.2% protection when primary exposure was restricted by IV treatment 12 and 24 h after infection, respectively. Exsheathed larvae secrete essentially a single dominant molecule of 23 kDa during the first 10 h of culture and in relatively small amounts (to.2 ng per larva per day). It is not until later that additional factors appear in ES products (Ey, 1988b) . If the same holds true for worms in viva, this 23 kDa antigen is likely to be the source of host-protective immunity. All the other L3 antigens were presumably made available to mice when dead larvae were used without success in immunization (Ey. 1988a) .
The strongest resistance to challenge was acquired when primary infections were terminated 46 days after infection at a time corresponding almost exactly to the L4 phase of infection, the preadult moult occurring 144166 h p.i. (Bryant, 1973 (1991) showed that L4 stages of H.po~y~yr~s induce protective immunity in isolation from L3 stages, although their experimental procedure involved subcutaneous rather than mucosal presentation of the antigens. Taken altogether. our studies establish that both larval stages release highly immunogenic antigens which elicit potent acquired immunity. This extraordinary immunogenicity of larval stages has to be contrasted with the prolonged survival of adult worms on primary exposure when patent infections last for more than 20 weeks in NIH mice (Robinson et a/., 1989) . Although immunizing infections in which larvae were allowed to progress to the patent adult stage were only briefly considered here (Experiments 7 and 9) it is evident from these that once adult worms developed, acquired immunity was significantly weakened confirming earlier reports (Behnke & Robinson. 1985; Dobson, Sitepu & Brindley, 1985; Enriquez, Cypess & Wassom, 1988; Kerboeuf & Jolivet, 1984) . The immunodepressive properties of adult parasites are believed to inhibit the acquisition of acquired resistance (Behnke et cd., 1983; Pritchard & Behnke. 1985) and exposure, limited to larval stages free from this influence, generated potent acquired resistance.
The greater resistance of mice experiencing a &day immunization was associated with a more intense antibody response to L4 and adult worm antigens (both IgG and IgGl). Indeed there was an almost perfect correlation between the intensity of the IgGl antibody response and the percentage protection 5 weeks after challenge infection, supporting the role of IgGl antibodies in mediating resistance to H.polygyrus (see Pritchard, Williams, Behnke & Lee, 1983; Williams & Behnke, 1983 (Pritchard ef al., 1984) . In the present study mice would have been sensitized only to L3 and L4 antigens depending on the duration of the priming infection and indeed, 2 weeks after exposure as well as on the day of challenge, groups experiencing a 12 and 24 h immunizing infection had antibody titres only marginally higher than naive mice. Then depending on the intensity of the secondary response, adult stages would have been experienced transiently and it was at this stage that anti-adult worm antibody titrcs rose significantly above control groups (Fig. 4) .
The strong recognition of low molecular weight adult worm antigens may be particularly significant. Antigens of 17. 18 and 20 kDa were imlllunoprecipitated by purified IgGl from hyperimmune sera. demonstrably effective in passive transfer (Pritchard ('I al., 1983) . In the present study these antigens were also recognized by the control hyperimmune serum. as expected. but there was considerably more reactivity in scra from mice sensitized by 4 ~6 day abbreviated infections, despite the fact that their overall reactivity against adult worm homogenate was less intense than that of HIM. Thus exposure to L4 stages, which possess antigens wzith comparable molecular weights although not necessarily the same molecules (Pritchard et al., 1984) led to preferential stimulation of a response against these antigens, indicating that some arc indeed likely to be identical or possess common epitopcs (Pritchard & Carr. 1987 One explanation may be that larval immunogens enter the circulation eliciting immunity whilst their IMFs keep cellular effecters at bay, protecting the larvae locally in their sites of development.
In support of the latter hypothesis. 6-day old L4 stages have been found to secrete < 14 kDa IMF (Losson, Lloyd & Soulsby. 1985) . Furthermore. larval IMFs may explain the resilience of tissue stages in the inflammed intestines of sensitized mice where development is slowed (Ey, 1988a) and despite the vigorous granulomatous reactions around them (Jones & Rubin, 1974) . many worms survive to return to the gut lumen as stunted preadults (Ey. 1988a) from which the majority are lost soon after arrival. Perhaps experience of dying L4 stages and their IMFs enables the host to resist larval and adult worm immunomodulation on secondary cxposurc, facilitating a s~i~cicntly intcnsc local inflammatory rcsponsc to damage the worms before their evasive strategies become fully effective, with consequent slower growth and loss from the gut lumen on completion of development.
Finally, our experiments have demonstrated unequivocally that the early developmental stage of H.pol_vgyrus, the parasitic L3, provides important stimuli for acquired resistance in responder strains of mice. Acquired resistance was enhanced when mice also experienced L4 stages and therefore protective immunity to H.polygyrus may be evoked by responses to antigen sets from both L3 and L4 stages. The crucial issues to tackle next will be to confirm the identification of the L3 antigens involved (vis-&vis Ey's 23 kDa antigen) and to determine whether the expression of acquired immunity in mice which have experienced only L3 stages is mediated by similar effector mechanisms to those known to act against L4 and preadult parasites or whether a novel combination is involved.
